Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Denise Croix"'
1
Understanding Factors Associated With Anaplastic Lymphoma Kinase Testing Delays in Patients With Non–Small Cell Lung Cancer in a Large Real-World Oncology Database
Autor: Yan Xiao, Denise Croix, Timothy Craig Allen, Julia Engstrom-Melnyk, Eric H. Bernicker, Stella Redpath, Baiyu Yang, Anup Abraham, R. Shah
Publikováno v: Archives of Pathology & Laboratory Medicine. 146:975-983
Context.— With multiple therapeutic options available for patients with advanced non–small cell lung cancer, the timely ordering and return of results to determine therapy are of critical importance. Objective.— To assess factors impacting anap
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2d9d0bb39a7ba2631e75af66e7a1630
https://doi.org/10.5858/arpa.2021-0029-oa
Zobrazit plný text záznamu
2
Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data
Autor: Eric H. Bernicker, Julia Engstrom-Melynk, Baiyu Yang, Yan Xiao, Denise Croix, Stella Redpath, Jaya Madala, R. Shah, Timothy Craig Allen, Anup Abraham
Publikováno v: Oncotarget
Objective: This study assessed the prevalence of anaplastic lymphoma kinase (ALK) rearrangements in US oncology practices. Materials and Methods: Using a nationwide real-world database, we included adults with advanced non-small cell lung cancer (aNS
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec3bd7a320a7033f040a098b51200c5d
http://europepmc.org/articles/PMC8590819
Zobrazit plný text záznamu
3
Adherence to National Comprehensive Cancer Network ALK Testing Guidelines for Patients with Advanced Non-Small Cell Lung Cancer in U.S. Community Medical Centers
Autor: Denise Croix, Timothy Craig Allen, Yan Xiao, R. Shah, Stella Redpath, Eric H. Bernicker, Julia Engstrom-Melnyk, Anup Abraham, Jaya Madala, Baiyu Yang
Publikováno v: The Oncologist
Background National Comprehensive Cancer Network (NCCN) guidelines recommend biomarker testing as the first step in the management of patients with advanced non‐small cell lung cancer (aNSCLC). We assessed anaplastic lymphoma kinase (ALK) testing r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6f4b71bd06d8cadd302351da2746732
https://doi.org/10.1002/onco.13779
Zobrazit plný text záznamu
5
Prevalence of ALK mutations in advanced NSCLC patients in the United States: Analysis with a real world oncology database
Autor: Eric H. Bernicker, Jaya Madala, Denise Croix, Yan Xiao, R. Shah, Julia Engstrom-Melnyk, Stella Redpath, Timothy Craig Allen, Anup Abraham, Baiyu Yang
Publikováno v: Journal of Clinical Oncology. 38:e21586-e21586
e21586 Background: ALK mutation rate is widely reported to be 3-7% of advanced non-small cell lung carcinoma (aNSCLC) patients. A cross-sectional study to assess the prevalence of ALK mutations in the real world was performed on the nationwide Flatir
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0b218bc73b7e172a69290f681588447a
https://doi.org/10.1200/jco.2020.38.15_suppl.e21586
Zobrazit plný text záznamu
6
Real-world testing compliance to NCCN guideline and factors of underutilization in U.S. community clinics
Autor: Yan Xiao, Eric H. Bernicker, Timothy Craig Allen, R. Shah, Stella Redpath, Denise Croix, Jaya Madala, Anup Abraham, Julia Engstrom-Melnyk, Baiyu Yang
Publikováno v: Journal of Clinical Oncology. 38:e21592-e21592
e21592 Background: Over the last 10 years, guideline recommendations for testing advanced non-small cell lung carcinomas (aNSCLC) have rapidly evolved with the identification of driver mutations and associated therapies. A retrospective study of the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f47584f77b93a6738cb5b38754f02098
https://doi.org/10.1200/jco.2020.38.15_suppl.e21592
Zobrazit plný text záznamu
7
Inflammation mediated metastasis: Immune induced epithelial-to-mesenchymal transition in inflammatory breast cancer cells
Autor: Hui Gao, Naoto T. Ueno, Neelima Reddy, Qiong Wu, Rajyalakshmi Luthra, Evan N. Cohen, Wendy A. Woodward, Michal Mego, Raul J. Garza, Simone Anfossi, Massimo Cristofanilli, Denise Croix, Sendurai A. Mani, S Tin, James M. Reuben, Antonio Giordano, Savitri Krishnamurthy, Bisrat G. Debeb
Publikováno v: PLoS ONE, Vol 10, Iss 7, p e0132710 (2015)
PLoS ONE
Inflammatory breast cancer (IBC) is the most insidious form of locally advanced breast cancer; about a third of patients have distant metastasis at initial staging. Emerging evidence suggests that host factors in the tumor microenvironment may intera
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a5647230b8ba5eba1102428931370ef
http://hdl.handle.net/11365/1129655
Zobrazit plný text záznamu
8
Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
Autor: Michael C. Carroll, Joseph M Ahearn, Robert G. Howard, Denise Croix, Xioning Zhou, Minghe Ma, Thomas L. Rothstein, Siegfried Goerg, Michael B. Fischer, Junrong Xia
Publikováno v: Immunity. 4(3)
Covalent attachment of activated products of the third component of complement to antigen enhances its immunogenicity, but the mechanism is not clear. This effect is mediated by specific receptors, mCR1 (CD35) and mCR2 (CD21), expressed primarily on
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf1a16d24af0e1964f6d06639c03868
https://pubmed.ncbi.nlm.nih.gov/8624815
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje